▲ Peaking
Business
🔮 fades ✗
Alzheimer's: Real-world study confirms Leqembi therapy benefits
The FDA has granted approval for an at-home subcutaneous starter dose of the Alzheimer's medication Leqembi, marking a shift in treatment administration.